Variation in selenoenzyme genes and prostate cancer risk and survival

Prostate

Volumn 73, Issue 7, 2013, Pages 734-742

  Geybels, Milan S ^a   Hutter, Carolyn M ^b,c   Kwon, Erika M ^d,e   Ostrander, Elaine A ^d   Fu, Rong ^b,c   Feng, Ziding ^b,c   Stanford, Janet L ^b,c   Peters, Ulrike ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetic variation; mortality; prostate cancer; risk; selenoenzyme genes

Indexed keywords

ENZYME; GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE PEROXIDASE 15; GLUTATHIONE PEROXIDASE 2; GLUTATHIONE PEROXIDASE 3; SELENIUM; SELENOENZYME; THIOREDOXIN REDUCTASE 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GLUTATHIONE PEROXIDASE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK FACTORS; SELENIUM;

EID: 84876291866     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22617     Document Type: Article

References (30)

1. Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR,. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 1996; 276 (24): 1957-1963.
2. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, Marshall JR, Clark LC,. Nutritional Prevention of Cancer Study G. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 2003; 91 (7): 608-612.
3. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301 (1): 39-51.
4. Hurst R, Hooper L, Norat T, Lau R, Aune D, Greenwood DC, Vieira R, Collings R, Harvey LJ, Sterne JA, Beynon R, Savovic J, Fairweather-Tait SJ,. Selenium and prostate cancer: Systematic review and meta-analysis. Am J Clin Nutr 2012; 96 (1): 111-122.
5. Peters U, Takata Y,. Selenium and the prevention of prostate and colorectal cancer. Mol Nutr Food Res 2008; 52 (11): 1261-1272.
6. Papp LV, Lu J, Holmgren A, Khanna KK,. From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid Redox Signal 2007; 9 (7): 775-806.
7. Rayman MP,. Selenium and human health. Lancet 2012; 379 (9822): 1256-1268.
8. Brigelius-Flohe R, Kipp A,. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009; 1790 (11): 1555-1568.
9. Halliwell B,. Oxidative stress and cancer: Have we moved forward ? Biochem J 2007; 401 (1): 1-11.
10. Arsova-Sarafinovska Z, Matevska N, Eken A, Petrovski D, Banev S, Dzikova S, Georgiev V, Sikole A, Erdem O, Sayal A, Aydin A, Dimovski AJ,. Glutathione peroxidase 1 (GPX1) genetic polymorphism, erythrocyte GPX activity, and prostate cancer risk. Int Urol Nephrol 2009; 41 (1): 63-70.
11. Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E, Akesson B, Rohrmann S, Linseisen J,. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev 2010; 19 (11): 2958-2968.
12. Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, Ma J,. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila) 2010; 3 (5): 604-610.
13. Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL,. Statin use and risk of prostate cancer: Results from a population-based epidemiologic study. Am J Epidemiol 2008; 168 (3): 250-260.
14. Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK,. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (10): 881-886.
15. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN,. Characterization of mammalian selenoproteomes. Science 2003; 300 (5624): 1439-1443.
16. Foster CB, Aswath K, Chanock SJ, McKay HF, Peters U,. Polymorphism analysis of six selenoprotein genes: Support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet 2006; 7: 56.
17. Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB,. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2008; 17 (5): 1144-1154.
18. Grambsch PM, Therneau TM,. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-526.
19. Moscow JA, Schmidt L, Ingram DT, Gnarra J, Johnson B, Cowan KH,. Loss of heterozygosity of the human cytosolic glutathione peroxidase I gene in lung cancer. Carcinogenesis 1994; 15 (12): 2769-2773.
20. Takata Y, King IB, Lampe JW, Burk RF, Hill KE, Santella RM, Kristal AR, Duggan DJ, Vaughan TL, Peters U,. Genetic variation in GPX1 is associated with GPX1 activity in a comprehensive analysis of genetic variations in selenoenzyme genes and their activity and oxidative stress in humans. J Nutr 2012; 142 (3): 419-426.
21. Jerome-Morais A, Wright ME, Liu R, Yang W, Jackson MI, Combs GF Jr, Diamond AM,. Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate 2012; 72 (9): 1006-1012.
22. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH,. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007; 67 (17): 8043-8050.
23. Burk RF, Hill KE,. Selenoprotein P-expression, functions, and roles in mammals. Biochim Biophys Acta 2009; 1790 (11): 1441-1447.
24. Moschos MP,. Selenoprotein P. Cell Mol Life Sci 2000; 57 (13-14): 1836-1845.
25. Calvo A, Xiao N, Kang J, Best CJ, Leiva I, Emmert-Buck MR, Jorcyk C, Green JE,. Alterations in gene expression profiles during prostate cancer progression: Functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors. Cancer Res 2002; 62 (18): 5325-5335.
26. Gonzalez-Moreno O, Boque N, Redrado M, Milagro F, Campion J, Endermann T, Takahashi K, Saito Y, Catena R, Schomburg L, Calvo A,. Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage. Prostate 2011; 71 (8): 824-834.
27. Meyer HA, Hollenbach B, Stephan C, Endermann T, Morgenthaler NG, Cammann H, Kohrle J, Jung K, Schomburg L,. Reduced serum selenoprotein P concentrations in German prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2009; 18 (9): 2386-2390.
28. Cooper ML, Adami HO, Gronberg H, Wiklund F, Green FR, Rayman MP,. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res 2008; 68 (24): 10171-10177.
29. Meplan C, Nicol F, Burtle BT, Crosley LK, Arthur JR, Mathers JC, Hesketh JE,. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status. Antioxid Redox Signal 2009; 11 (11): 2631-2640.
30. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, Kwon SY, Moustafa ME, Carlson BA, Berry MJ, Lee BJ, Hatfield DL, Diamond AM, Gladyshev VN,. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 2000; 275 (45): 35540-35547.